Viewing Study NCT01487759


Ignite Creation Date: 2025-12-24 @ 2:29 PM
Ignite Modification Date: 2026-01-03 @ 4:00 PM
Study NCT ID: NCT01487759
Status: COMPLETED
Last Update Posted: 2011-12-12
First Post: 2011-12-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prebiotic Effect on Metabolites in Crohn's Disease
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003424', 'term': 'Crohn Disease'}], 'ancestors': [{'id': 'D015212', 'term': 'Inflammatory Bowel Diseases'}, {'id': 'D005759', 'term': 'Gastroenteritis'}, {'id': 'D005767', 'term': 'Gastrointestinal Diseases'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D007410', 'term': 'Intestinal Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C008315', 'term': 'maltodextrin'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR']}, 'primaryPurpose': 'BASIC_SCIENCE', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 67}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2008-03'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2011-12', 'completionDateStruct': {'date': '2009-07'}, 'lastUpdateSubmitDate': '2011-12-09', 'studyFirstSubmitDate': '2011-12-06', 'studyFirstSubmitQcDate': '2011-12-06', 'lastUpdatePostDateStruct': {'date': '2011-12-12', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2011-12-07', 'type': 'ESTIMATED'}}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Crohn Disease']}, 'descriptionModule': {'briefSummary': "The purpose of this study is to investigate the influence of the prebiotic oligofructose enriched inulin on the metabolite pattern in Crohn's disease patients."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* crohn's disease\n\nExclusion Criteria:\n\n* severe crohn's disease (harvey bradshaw index \\>12)\n* pregnancy\n* history of colectomy\n* use of antibiotics 4-wks before start of the study\n* use of sulfapyridine\n* use of commercially available prebiotics and probiotics"}, 'identificationModule': {'nctId': 'NCT01487759', 'briefTitle': "Prebiotic Effect on Metabolites in Crohn's Disease", 'organization': {'class': 'OTHER', 'fullName': 'KU Leuven'}, 'officialTitle': "Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients", 'orgStudyIdInfo': {'id': 'ML4789'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Prebiotic', 'interventionNames': ['Dietary Supplement: Oligofructose enriched inulin']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'interventionNames': ['Dietary Supplement: Maltodextrin']}], 'interventions': [{'name': 'Oligofructose enriched inulin', 'type': 'DIETARY_SUPPLEMENT', 'armGroupLabels': ['Prebiotic']}, {'name': 'Maltodextrin', 'type': 'DIETARY_SUPPLEMENT', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '3000', 'city': 'Leuven', 'country': 'Belgium', 'facility': 'KULeuven', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'KU Leuven', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal investigator', 'investigatorFullName': 'Kristin Verbeke', 'investigatorAffiliation': 'KU Leuven'}}}}